Seres Therapeutics, Inc.·4

Jul 6, 7:23 PM ET

Kender Richard N 4

4 · Seres Therapeutics, Inc. · Filed Jul 6, 2022

Insider Transaction Report

Form 4
Period: 2022-07-05
Kender Richard N
DirectorSee Remarks
Transactions
  • Award

    COMMON STOCK

    2022-07-05$3.15/sh+63,492$200,00063,492 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION